The role of shear-induced transforming growth factor-β signaling in the endothelium

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 11, 2013, Pages 2608-2617

  Walshe, Tony E ^a   Dela Paz, Nathaniel G ^a,c   D'Amore, Patricia A ^a,b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

endothelium; hemodynamics; KLF2 protein, human; nitric oxide; transforming growth factor beta

Indexed keywords

AGENTS AFFECTING PROTEIN METABOLISM; ENDOTHELIAL NITRIC OXIDE SYNTHASE; KRUPPEL LIKE FACTOR 2; NITRIC OXIDE; SB 525334; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHEAR STRESS; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

ENDOTHELIUM; HEMODYNAMICS; KLF2 PROTEIN, HUMAN; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMIDAZOLES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; NITRIC OXIDE; PROTEIN-SERINE-THREONINE KINASES; QUINOXALINES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; STRESS, MECHANICAL; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84887071743     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.113.302161     Document Type: Article

References (66)

1. Mack PJ, Zhang Y, Chung S, Vickerman V, Kamm RD, García- Cardeña G. Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling. J Biol Chem. 2009;284:8412-8420.
2. Wojciak-Stothard B. Endothelial cell migration under fow. Methods Mol Biol. 2011;769:137-147.
3. Walshe TE, Connell P, Cryan L, Ferguson G, O'Brien C, Cahill PA. The role of pulsatile fow in controlling microvascular retinal endo-thelial and pericyte cell apoptosis and proliferation. Cardiovasc Res. 2011;89:661-670.
4. ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol. 2007;8:857-869.
5. Qian SW, Burmester JK, Tsang ML, Weatherbee JA, Hinck AP, Ohlsen DJ, Sporn MB, Roberts AB. Binding affnity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule. J Biol Chem. 1996;271:30656-30662.
6. Frutkin AD, Otsuka G, Stempien-Otero A, Sesti C, Du L, Jaffe M, Dichek HL, Pennington CJ, Edwards DR, Nieves-Cintrón M, Minter D, Preusch M, Hu JH, Marie JC, Dichek DA. TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol. 2009;29:1251-1257.
7. Letarte M, McDonald ML, Li C, Kathirkamathamby K, Vera S, Pece-Barbara N, Kumar S. Reduced endothelial secretion and plasma levels of transforming growth factor-beta1 in patients with hereditary hemorrhagic telangiectasia type 1. Cardiovasc Res. 2005;68:155-164.
8. Walshe TE. TGF-beta and microvessel homeostasis. Microvasc Res. 2010;80:166-173.
9. Wakefeld LM, Stuelten C. Keeping order in the neighborhood: new roles for TGFbeta in maintaining epithelial homeostasis. Cancer Cell. 2007;12:293-295.
10. Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12:642-649.
11. Walshe TE, Leach LL, D'Amore PA. TGF-β signaling is required for maintenance of retinal ganglion cell differentiation and survival. Neuroscience. 2011;189:123-131.
12. Walshe TE, Dole VS, Maharaj AS, Patten IS, Wagner DD, D'Amore PA. Inhibition of VEGF or TGF-{beta} signaling activates endothe-lium and increases leukocyte rolling. Arterioscler Thromb Vasc Biol. 2009;29:1185-1192.
13. Walshe TE, Saint-Geniez M, Maharaj AS, Sekiyama E, Maldonado AE, D'Amore PA. TGF-beta is required for vascular barrier function, endo-thelial survival and homeostasis of the adult microvasculature. PLoS One. 2009;4:e5149.
14. Maharaj AS, Walshe TE, Saint-Geniez M, Venkatesha S, Maldonado AE, Himes NC, Matharu KS, Karumanchi SA, D'Amore PA. VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma. J Exp Med. 2008;205:491-501.
15. Darland DC, D'Amore PA. TGF beta is required for the formation of capillary-like structures in three-dimensional cocultures of 10T1/2 and endothelial cells. Angiogenesis. 2001;4:11-20.
16. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and hetero-typic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol. 1998;141:805-814.
17. Ramsauer M, D'Amore PA. Contextual role for angiopoietins and TGFbeta1 in blood vessel stabilization. J Cell Sci. 2007;120(pt 10):1810-1817.
18. Suzuki T, Aizawa K, Matsumura T, Nagai R. Vascular implications of the Krüppel-like family of transcription factors. Arterioscler Thromb Vasc Biol. 2005;25:1135-1141.
19. Atkins GB, Jain MK. Role of Krüppel-like transcription factors in endo-thelial biology. Circ Res. 2007;100:1686-1695.
20. Dekker RJ, van Soest S, Fontijn RD, et al. Prolonged fuid shear stress induces a distinct set of endothelial cell genes, most specifcally lung Kruppel-like factor (KLF2). Blood. 2002;100:1689-1698.
21. Lin Z, Kumar A, SenBanerjee S, Staniszewski K, Parmar K, Vaughan DE, Gimbrone MA Jr, Balasubramanian V, García-Cardeña G, Jain MK. Kruppel-like factor 2 (KLF2) regulates endothelial thrombotic function. Circ Res. 2005;96:e48-e57.
22. SenBanerjee S, Lin Z, Atkins GB, Greif DM, Rao RM, Kumar A, Feinberg MW, Chen Z, Simon DI, Luscinskas FW, Michel TM, Gimbrone MA Jr, García- Cardeña G, Jain MK. KLF2 is a novel tran-scriptional regulator of endothelial proinfammatory activation. J Exp Med. 2004;199:1305-1315.
23. Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JC, Voorberg J, Pannekoek H, Horrevoets AJ. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood. 2006;107:4354-4363.
24. Dekker RJ, van Thienen JV, Rohlena J, de Jager SC, Elderkamp YW, Seppen J, de Vries CJ, Biessen EA, van Berkel TJ, Pannekoek H, Horrevoets AJ. Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes. Am J Pathol. 2005;167:609-618.
25. Parmar KM, Larman HB, Dai G, Zhang Y, Wang ET, Moorthy SN, Kratz JR, Lin Z, Jain MK, Gimbrone MA Jr, García-Cardeña G. Integration of fow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest. 2006;116:49-58.
26. Ahluwalia A, Foster P, Scotland RS, McLean PG, Mathur A, Perretti M, Moncada S, Hobbs AJ. Antiinfammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci USA. 2004;101:1386-1391.
27. Gélinas DS, Bernatchez PN, Rollin S, Bazan NG, Sirois MG. Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways. Br J Pharmacol. 2002; 137:1021-1030.
28. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman DH, Husain M, Letarte M. A role for endoglin in coupling eNOS activity and regulating vascular tone revealed in hereditary hemorrhagic telangiectasia. Circ Res. 2005;96:684-692.
29. Dardik A, Chen L, Frattini J, Asada H, Aziz F, Kudo FA, Sumpio BE. Differential effects of orbital and laminar shear stress on endothelial cells. J Vasc Surg. 2005;41:869-880.
30. Lin K, Hsu PP, Chen BP, Yuan S, Usami S, Shyy JY, Li YS, Chien S. Molecular mechanism of endothelial growth arrest by laminar shear stress. Proc Natl Acad Sci USA. 2000;97:9385-9389.
31. Akimoto S, Mitsumata M, Sasaguri T, Yoshida Y. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-depen-dent kinase inhibitor p21(Sdi1/Cip1/Waf1). Circ Res. 2000;86:185-190.
32. Fledderus JO, van Thienen J V, Boon RA, Dekker RJ, Rohlena J, Volger OL, Bijnens AP, Daemen MJ, Kuiper J, van Berkel TJ, Pannekoek H, Horrevoets AJ. Prolonged shear stress and KLF2 suppress constitutive proinfammatory transcription through inhibition of ATF2. Blood. 2007;109:4249-4257.
33. Korff T, Aufgebauer K, Hecker M. Cyclic stretch controls the expression of CD40 in endothelial cells by changing their transforming growth factor-beta1 response. Circulation. 2007;116:2288-2297.
34. Baker AB, Ettenson DS, Jonas M, Nugent MA, Iozzo RV, Edelman ER. Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ Res. 2008;103:289-297.
35. Ohno M, Cooke JP, Dzau VJ, Gibbons GH. Fluid shear stress induces endothe-lial transforming growth factor beta-1 transcription and production. Modulation by potassium channel blockade. J Clin Invest. 1995;95:1363-1369.
36. Lum RM, Wiley LM, Barakat AI. Infuence of different forms of fuid shear stress on vascular endothelial TGF-beta1 mRNA expression. Int J Mol Med. 2000;5:635-641.
37. Egorova AD, Van der Heiden K, Van de Pas S, Vennemann P, Poelma C, DeRuiter MC, Goumans MJ, Gittenberger-de Groot AC, ten Dijke P, Poelmann RE, Hierck BP. Tgfβ/Alk5 signaling is required for shear stress induced klf2 expression in embryonic endothelial cells. Dev Dyn. 2011;240:1670-1680.
38. Negishi M, Lu D, Zhang YQ, Sawada Y, Sasaki T, Kayo T, Ando J, Izumi T, Kurabayashi M, Kojima I, Masuda H, Takeuchi T. Upregulatory expression of furin and transforming growth factor-beta by fuid shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21:785-790.
39. Cucina A, Sterpetti AV, Pupelis G, Fragale A, Lepidi S, Cavallaro A, Giustiniani Q, Santoro D'Angelo L. Shear stress induces changes in the morphology and cytoskeleton organisation of arterial endothelial cells. Eur J Vasc Endovasc Surg. 1995;9:86-92.
40. Boon RA, Fledderus JO, Volger OL, van Wanrooij EJ, Pardali E, Weesie F, Kuiper J, Pannekoek H, ten Dijke P, Horrevoets AJ. KLF2 suppresses TGF-beta signaling in endothelium through induction of Smad7 and inhibition of AP-1. Arterioscler Thromb Vasc Biol. 2007;27:532-539.
41. Boon RA, Leyen TA, Fontijn RD, Fledderus JO, Baggen JM, Volger OL, van Nieuw Amerongen GP, Horrevoets AJ. KLF2-induced actin shear fbers control both alignment to fow and JNK signaling in vascular endo-thelium. Blood. 2010;115:2533-2542.
42. Li J, Foitzik K, Calautti E, Baden H, Doetschman T, Dotto GP. TGF-beta3, but not TGF-beta1, protects keratinocytes against 12-O-tetradecanoylphorbol-13- acetate-induced cell death in vitro and in vivo. J Biol Chem. 1999;274:4213-4219.
43. Kingston PA, Sinha S, Appleby CE, David A, Verakis T, Castro MG, Lowenstein PR, Heagerty AM. Adenovirus-mediated gene transfer of transforming growth factor-beta3, but not transforming growth factor-beta1, inhibits constrictive remodeling and reduces luminal loss after coronary angioplasty. Circulation. 2003;108:2819-2825.
44. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specifc. J Biol Chem. 1997;272:18000-18006.
45. De Crescenzo G, Grothe S, Zwaagstra J, Tsang M, O'Connor-McCourt MD. Real-time monitoring of the interactions of transforming growth factor-beta (TGF-beta) isoforms with latency-associated protein and the ectodomains of the TGF-beta type II and III receptors reveals different kinetic models and stoichiometries of binding. J Biol Chem. 2001;276:29632-29643.
46. Radaev S, Zou Z, Huang T, Lafer EM, Hinck AP, Sun PD. Ternary complex of transforming growth factor-beta1 reveals isoform-specifc ligand recognition and receptor recruitment in the superfamily. J Biol Chem. 2010;285:14806-14814.
47. Yamagishi T, Nakajima Y, Nakamura H. Expression of TGFbeta3 RNA during chick embryogenesis: a possible important role in cardiovascular development. Cell Tissue Res. 1999;298:85-93.
48. Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fbrotic human lung. Thorax. 2001;56:549-556.
49. Muraoka N, Shum L, Fukumoto S, Nomura T, Ohishi M, Nonaka K. Transforming growth factor-beta3 promotes mesenchymal cell proliferation and angiogenesis mediated by the enhancement of cyclin D1, Flk-1, and CD31 gene expression during CL/Fr mouse lip fusion. Birth Defects Res A Clin Mol Teratol. 2005;73:956-965.
50. Holifeld JS, Arlen AM, Runyan RB, Tomanek RJ. TGF-beta1,-beta2 and-beta3 cooperate to facilitate tubulogenesis in the explanted quail heart. J Vasc Res. 2004;41:491-498.
51. Jin ZG, Ueba H, Tanimoto T, Lungu AO, Frame MD, Berk BC. Ligand-independent activation of vascular endothelial growth factor receptor 2 by fuid shear stress regulates activation of endothelial nitric oxide synthase. Circ Res. 2003;93:354-363.
52. Young A, Wu W, Sun W, Benjamin Larman H, Larman HB, Wang N, Li YS, Shyy JY, Chien S, García-Cardeña G. Flow activation of AMP-activated protein kinase in vascular endothelium leads to Krüppel-like factor 2 expression. Arterioscler Thromb Vasc Biol. 2009;29:1902-1908.
53. Walshe TE, Ferguson G, Connell P, O'Brien C, Cahill PA. Pulsatile fow increases the expression of eNOS, ET-1, and prostacyclin in a novel in vitro coculture model of the retinal vasculature. Invest Ophthalmol Vis Sci. 2005;46:375-382.
54. Haefiger IO, Meyer P, Flammer J, Lüscher TF. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? Surv Ophthalmol. 1994;39:123-132.
55. Dorner GT, Garhofer G, Kiss B, Polska E, Polak K, Riva CE, Schmetterer L. Nitric oxide regulates retinal vascular tone in humans. Am J Physiol Heart Circ Physiol. 2003;285:H631-H636.
56. Hida A, Kawakami A, Miyashita T, Yamasaki S, Nakashima K, Tanaka F, Izumi Y, Tamai M, Huang M, Ida H, Nakamura H, Origuchi T, Ueki Y, Eguchi K. Nitric oxide acts on the mitochondria and protects human endothelial cells from apoptosis. J Lab Clin Med. 2004;144:148-155.
57. Dimmeler S, Haendeler J, Nehls M, Zeiher AM. Suppression of apopto-sis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J Exp Med. 1997;185:601-607.
58. Tsutsui M, Shimokawa H, Otsuji Y, Yanagihara N. Pharmacology & Therapeutics. Pharmacol Ther. 2010;128:499-508.
59. Atochin DN, Huang PL. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pfugers Arch. 2010;460:965-974.
60. Le Gouill E, Jimenez M, Binnert C, et al. Endothelial nitric oxide syn-thase (eNOS) knockout mice have defective mitochondrial beta-oxidation. Diabetes. 2007;56:2690-2696.
61. Stauss HM, Gödecke A, Mrowka R, Schrader J, Persson PB. Enhanced blood pressure variability in eNOS knockout mice. Hypertension. 1999;33: 1359-1363.
62. Gödecke A, Decking UK, Ding Z, Hirchenhain J, Bidmon HJ, Gödecke S, Schrader J. Coronary hemodynamics in endothelial NO synthase knockout mice. Circ Res. 1998;82:186-194.
63. Wilson RI, Yanovsky J, Gödecke A, Stevens DR, Schrader J, Haas HL. Endothelial nitric oxide synthase and LTP. Nature. 1997;386:338.
64. Shesely EG, Maeda N, Kim HS, Desai KM, Krege JH, Laubach VE, Sherman PA, Sessa WC, Smithies O. Elevated blood pressures in mice lacking endothe-lial nitric oxide synthase. Proc Natl Acad Sci USA. 1996;93:13176-13181.
65. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 1995;377:239-242.
66. Ma S, Ma CC. Recent development in pleiotropic effects of statins on cardiovascular disease through regulation of transforming growth factor-beta superfamily. Cytokine Growth Factor Rev. 2011;22:167-175.